European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
University of Huddersfield Featured PhD Programmes
King’s College London Featured PhD Programmes
Newcastle University Featured PhD Programmes
University of Sheffield Featured PhD Programmes
United Kingdom
Bradford×
10 miles
    2. >
    3. >
    4. >

Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships in Bradford

We have 23 Pharmacy / Pharmaceutics PhD Projects, Programs & Scholarships in Bradford

  • Pharmacy / Pharmaceutics×
  • United Kingdom×
  • Bradford×
  • clear all
Order by 
Showing 1 to 10 of 23
  Novel prodrug anti-metastatic therapy for neuroblastoma
University of Bradford Faculty of Life Sciences
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer
Application Deadline: 30 April 2019
This is one of three new fully-funded PhD studentships in the new Institute of Cancer Therapeutics Doctoral Training Centre (ICT-DTC) at the University of Bradford.
Details
Type/Funding
  Development of stimuli-responsive metallosupramolecular architectures for sensing and/or delivery of medicine for the treatment of solid tumours
University of Bradford Faculty of Life Sciences
  Research Group: Chemistry and Biosciences
  Dr D Petty, Dr M Najafzadeh, Dr S Pike
Applications accepted all year round
Applications are invited for a new self-funded PhD opportunity in the School of Chemistry & Biosciences at the University of Bradford.
Details
Type/Funding
  Targeting BETA-Cell Failure in Lean Patients With Type 2 Diabetes
University of Leeds Faculty of Medicine and Health
  Dr E Levelt, Prof S Plein
Application Deadline: 15 April 2019
Heart failure is a major health concern in patients with type 2 diabetes. While the focus of prevention in type 2 diabetes is on obesity, many people with type 2 diabetes are not overweight and it is poorly understood why lean people develop type 2 diabetes and how exactly this should be addressed.
Details
Type/Funding
  The role of community pharmacists in developing and implementing deprescribing initiatives in primary care
University of Leeds Faculty of Medicine and Health
  Dr D Alldred
Application Deadline: 26 April 2019
This is an exciting opportunity to undertake a PhD within the Yorkshire and Humber Patient Safety Translational Research Centre (Yorkshire and Humber PSTRC), a partnership between the University of Leeds and Bradford Teaching Hospitals Foundation Trust.
Details
Type/Funding
  Targeting addiction to a breast cancer metastasis survival pathway by inhibition of RAN GTPase
University of Bradford Faculty of Life Sciences
  Research Group: Institute of Cancer Therapeutics
  Dr S Shnyder, Prof M El-Tanani, Dr S Betmouni
Applications accepted all year round
Metastatic cancer is a major global health burden. Each year, eleven million new cases of cancer are diagnosed worldwide, including 5 million cases in industrialized countries.
Details
Type/Funding
  Ran GTPase as a potential novel therapeutic target in EMT transdifferentiation and breast cancer stem cell (BCSC) survival during metastatic development
University of Bradford Faculty of Life Sciences
  Research Group: Institute of Cancer Therapeutics
  Prof R Morgan, Prof M El-Tanani, Dr M Isreb, Dr M Najafzadeh
Applications accepted all year round
Breast cancer is the leading cause of cancer death in women worldwide. Accumulating evidence suggests that local disease recurrence and metastatic lesions, the major causes of patient mortality, are due to a subset of aggressive cells termed cancer stem cells (CSCs).
Details
Type/Funding
  Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)
University of Bradford Faculty of Life Sciences
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim
Applications accepted all year round
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
Details
Type/Funding
  Pharmaceutical cocrystallisation for improved medicines
University of Bradford Faculty of Life Sciences
  Research Group: Medicines Development and Pharmaceutical Sciences
  Dr V Vangala, Prof A Paradkar
Applications accepted all year round
Active pharmaceutical ingredients (APIs) are frequently delivered to the patients in the solid-state formulation. Yet, therapeutic effectiveness of a dosage form depends on the bioavailability, stability and also on the manufacturability of the dosage form.
Details
Type/Funding
  Identifying glucose-dependent mechanisms underlying risk factors for Alzheimer’s disease
University of Bradford Faculty of Life Sciences
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr S McLean
Applications accepted all year round
Several risk factors for Alzheimer’s disease including diabetes and midlife obesity are age-dependent and have an obvious metabolic component resulting in impaired glucose metabolism.
Details
Type/Funding
  Determining brain glycosylation in ageing and Alzheimer’s disease
University of Bradford Faculty of Life Sciences
  Research Group: Pharmacology and Experimental Therapeutics
  Dr R Williamson, Dr C Sutton
Applications accepted all year round
Increasing age is associated with lower levels of cognitive performance; concomitant with this is a decrease in brain glucose metabolism.
Details
Type/Funding
Show 10 15 30 per page
4k+

PhD Project & Programmes
Search for PhDs
PhDs by Subject
PhDs by Institution
PhDs by Country
PhDs by Email
Info for students
Postgraduate Open Days
PhD Study Guides
PhD Study Abroad
Funding Your PhD
Postgraduate Advice Forum
Postgraduate Email Updates
Info for advertisers
Advertise your PhD Project & Programmes
Provider Login
Display Advertising
Targeted Emails

FindAPhD. Copyright 2005-2019
All rights reserved.